Cumberland Pharmaceuticals Inc
CPIX
Revenue
9.85M
▲1.35M▲15.90%
3 Months ChangeAssets
78.52M
▼-2.99M▼-3.67%
3 Months ChangeLiabilities
52.49M
▼-1.83M▼-3.37%
3 Months ChangeFree Cash Flow
-2.18M
▼-652.80k▼-42.79%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0001628280-24-036529
2024-08-06
Form 8-K
ID: 0001628280-24-035262
2024-05-10
Form 10-Q
ID: 0001628280-24-022658
2024-05-07
Form 8-K
ID: 0001628280-24-021185
2024-04-29
Form 8-K
ID: 0001628280-24-019053
2024-03-20
Form 8-K
ID: 0001628280-24-012261
2024-03-05
Form 8-K
ID: 0001628280-24-009006
2023-11-13
Form 10-Q
ID: 0001628280-23-038418
2023-11-07
Form 8-K
ID: 0001628280-23-037446
2023-10-13
Form 8-K
ID: 0001628280-23-034316